title: Stability of association of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with liposomes is composition dependent.
abstract: The ether lipid, 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (ET-18-OCH3), has anticancer activity, but it has serious side-effects, including hemolysis, which prevent its optimal use. We surmised if ET-18-OCH3 could be stably associated with liposomes, less free ET-18-OCH3 would be available for lytic interaction with red cells. Liposome composition variables investigated included acyl chain saturation, phospholipid head group and mole ratio of Chol and ET-18-OCH3. It was found that attenuation of hemolysis was strongly liposome composition dependent. Some ET-18-OCH3 liposome compositions were minimally hemolytic. For example, whereas the HI5 (drug concentration required to cause 5% human red cell lysis) was 5-6 microM for free ET-18-OCH3, it was approximately 250 microM for DOPC (dioleoylphosphatidylcholine):Chol (cholesterol):DOPE-GA (glutaric acid derivatized DOPE):ET-18-OCH3, (4:3:1:2) and 640 microM for DOPE (dioleyolphosphatidylethanolamine):Chol:DOPE-GA:ET-18-OCH3 (4:3:1:2) liposomes. Efflux of carboxyfluorescein (CF) from liposomes and Langmuir trough determinations of mean molecular area of lipids in monolayers (MMAM) were used as indicators of membrane packing and stability. Incorporation of ET-18-OCH3 in liposomes reduced the MMAM. Reduction in CF permeation was correlated with reduction in hemolysis. The most stable liposomes included components, such as cholesterol, DOPC and DOPE, which have complementary shapes to ET-18-OCH3.
authors.affiliation: The Liposome Company Inc., Princeton Forrestal Center, NJ 08540-6619, USA.
authors.forename: E
authors.initials: E
authors.lastname: Mayhew
authors.forename: I
authors.initials: I
authors.lastname: Ahmad
authors.forename: S
authors.initials: S
authors.lastname: Bhatia
authors.forename: R
authors.initials: R
authors.lastname: Dause
authors.forename: J
authors.initials: J
authors.lastname: Filep
authors.forename: A S
authors.initials: AS
authors.lastname: Janoff
authors.forename: E
authors.initials: E
authors.lastname: Kaisheva
authors.forename: W R
authors.initials: WR
authors.lastname: Perkins
authors.forename: Y
authors.initials: Y
authors.lastname: Zha
authors.forename: J C
authors.initials: JC
authors.lastname: Franklin
mesh_terms: D002499:Centrifugation, Density Gradient; D002784:Cholesterol / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism; D005452:Fluoresceins / Q000493:pharmacokinetics; D005456:Fluorescent Dyes / Q000493:pharmacokinetics; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008081:Liposomes / Q000737:chemistry* / Q000378:metabolism; D008854:Microscopy, Electron; D010539:Permeability; D010713:Phosphatidylcholines / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000378:metabolism; D010742:Phospholipid Ethers / Q000737:chemistry* / Q000494:pharmacology
chemical_list: D005452:Fluoresceins; D005456:Fluorescent Dyes; D008081:Liposomes; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010742:Phospholipid Ethers; C026659:edelfosine; C024098:6-carboxyfluorescein; D002784:Cholesterol